Previous close | 25.49 |
Open | 27.00 |
Bid | 20.22 x 200 |
Ask | 33.28 x 200 |
Day's range | 25.67 - 28.69 |
52-week range | 17.53 - 59.84 |
Volume | |
Avg. volume | 868,366 |
Market cap | 2.195B |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | -8.37 |
Earnings date | 25 Apr 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 27.91 |
Q1 2024 PTC Therapeutics Inc Earnings Call
Unveiling robust financial performance and strategic expansions in Q1 2024, PTC Therapeutics Inc (PTCT) sets a promising trajectory.
Although the revenue and EPS for PTC Therapeutics (PTCT) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.